| Sorry man, I know several people who were injured by some of these meds. It is not talked about enough when they prescribe them. Regarding Genomind, these are really limited in how much they will help. They test a limited amount of genes that "might" change drug efficacy. Even taking into account the CYP genetics, if someone is anemic these enzymes will function more slowly so emvironment will trump genetics. https://jamanetwork.com/journals/jama/article-abstract/19539... "At this time, DTC advertisements are inappropriate, given the public's limited sophistication regarding genetics and the lack of comprehensive premarket review of tests or oversight of advertisement content." And from the really the only study claiming that Genomind is effective, from their website: https://genomind.com/the-science/ Citation: Perlis RH, et al. Pharmacogenetic testing among patients with mood and anxiety disorders is associated with decreased utilization and cost: A propensity-score matched study. Depression & Anxiety. 2018;35(10):946-952. doi:10.1002/da.22742 "Dr. Imbens reports personal fees from Genomind, for experimental design related to the submitted work, and personal fees from Eli Lilly, outside the submitted work." And if you look through all of those studies you will find they were funded by Genomind. |